Epac2-deficiency leads to more severe retinal swelling, glial reactivity and oxidative stress in transient middle cerebral artery occlusion induced ischemic retinopathy

Science China Life Sciences

Volumn 58, Issue 6, 2015, Pages 521-530

  Liu, Jin ^a   Yeung, Patrick Ka Kit ^a   Cheng, Lu ^a   Lo, Amy Cheuk Yin ^a   Chung, Stephen Sum Man ^b   Chung, Sookja Kim ^a,c  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b BNU HKBU UNITED INTERNATIONAL COLLEGE   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Epac; ischemia; retina; retinopathy

Indexed keywords

MUS;

AQP4 PROTEIN, MOUSE; AQUAPORIN 4; EPAC PROTEIN, MOUSE; GLIAL FIBRILLARY ASTROCYTIC PROTEIN, MOUSE; GUANINE NUCLEOTIDE EXCHANGE FACTOR; NERVE PROTEIN; PEROXIREDOXIN 6; PRDX6 PROTEIN, MOUSE; RAPGEF4 PROTEIN, MOUSE;

ANIMAL; C57BL MOUSE; CEREBRAL ARTERY DISEASE; DEFICIENCY; FEMALE; GENETICS; GENOTYPE; GLIA; IMMUNOHISTOCHEMISTRY; ISCHEMIA; MALE; METABOLISM; MOUSE; OXIDATIVE STRESS; PATHOLOGY; PHYSIOLOGY; REPERFUSION INJURY; RETINA; RETINA DISEASE; TRANSGENIC MOUSE;

ANIMALS; AQUAPORIN 4; FEMALE; GENOTYPE; GUANINE NUCLEOTIDE EXCHANGE FACTORS; IMMUNOHISTOCHEMISTRY; INFARCTION, MIDDLE CEREBRAL ARTERY; ISCHEMIA; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; NEUROGLIA; OXIDATIVE STRESS; PEROXIREDOXIN VI; REPERFUSION INJURY; RETINA; RETINAL DISEASES;

EID: 84931566593     PISSN: 16747305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11427-015-4860-1     Document Type: Article

References (41)

1. Osborne NN, Casson RJ, Wood JPM, Chidlow G, Graham M, Melena J. Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog Retin Eye Res, 2004, 23: 91–147
2. Buchi ER. Cell death in the rat retina after a pressure-induced ischaemia-reperfusion insult: an electron microscopic study. I. Ganglion cell layer and inner nuclear layer. Exp Eye Res, 1992, 55: 605–613
3. Lafuente MP, Villegas-Pérez MP, Sellés-Navarro I, Mayor-Torroglosa S, de Imperial JM, Vidal-Sanz M. Retinal ganglion cell death after acute retinal ischemia is an ongoing process whose severity and duration depends on the duration of the insult. Neuroscience, 2002, 109: 157–168
4. Nucci C, Tartaglione R, Rombolà L, Morrone LA, Fazzi E, Bagetta G. Neurochemical evidence to implicate elevated glutamate in the mechanisms of high intraocular pressure (IOP)-induced retinal ganglion cell death in rat. Neurotoxicology, 2005, 26: 935–941
5. Yamamoto H, Schmidt-Kastner R, Hamasaki DI, Yamamoto H, Parel JM. Complex neurodegeneration in retina following moderate ischemia induced by bilateral common carotid artery occlusion in Wistar rats. Exp Eye Res, 2006, 82: 767–779
6. Bringmann A, Francke M, Pannicke T, Biedermann B, Faude F, Enzmann V, Wiedemann P, Reichelt W, Reichenbach A. Human Muller glial cells: altered potassium channel activity in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci, 1999, 40: 3316–3323
7. Kim IB, Kim KY, Joo CK, Lee MY, Oh SJ, Chung JW, Chun MH. Reaction of Muller cells after increased intraocular pressure in the rat retina. Exp Brain Res, 1998, 121: 419–424
8. Da T, Verkman AS. Aquaporin-4 gene disruption in mice protects against impaired retinal function and cell death after ischemia. Invest Ophthalmol Vis Sci, 2004, 45: 4477–4483
9. Yanoff M, Fine BS, Brucker AJ, Eagle Jr. Ralph C. Pathology of human cystoid macular edema. Surv Ophthalmol, 1984, 28(Suppl): 505–511
10. Cheung AK, Fung MK, Lo AC, Lam TT, So KF, Chung SS, Chung SK. Aldose reductase deficiency prevents diabetes-induced bloodretinal barrier breakdown, apoptosis, and glial reactivation in the retina of db/db mice. Diabetes, 2005, 54: 3119–3125
11. Cheung AK, Lo AC, So KF, Chung SS, Chung SK. Gene deletion and pharmacological inhibition of aldose reductase protect against retinal ischemic injury. Exp Eye Res, 2007, 85: 608–616
12. Gloerich M, Bos JL. Epac: defining a new mechanism for cAMP action. Annu Rev Pharmacol Toxicol, 2010, 50: 355–375
13. Bos JL. Linking Rap to cell adhesion. Curr Opin Cell Biol, 2005, 17: 123–128
14. Rampersad SN, Ovens JD, Huston E, Umana MB, Wilson LS, Netherton SJ, Lynch MJ, Baillie GS, Houslay MD, Maurice DH. Cyclic AMP phosphodiesterase 4D (PDE4D) Tethers EPAC1 in a vascular endothelial cadherin (VE-Cad)-based signaling complex and controls cAMP-mediated vascular permeability. J Biol Chem, 2010, 285: 33614–33622
15. Nijholt IM, Dolga AM, Ostroveanu A, Luiten PG, Schmidt M, Eisel UL. Neuronal AKAP150 coordinates PKA and Epac-mediated PKB/Akt phosphorylation. Cell Signal, 2008, 20: 1715–1724
16. Penzes P, Woolfrey KM, Srivastava DP. Epac2-mediated dendritic spine remodeling: implications for disease. Mol Cell Neurosci, 2011, 46: 368–380
17. Woolfrey KM, Srivastava DP, Photowala H, Yamashita M, Barbolina MV, Cahill ME, Xie Z, Jones KA, Quilliam LA, Prakriya M, Penzes P. Epac2 induces synapse remodeling and depression and its disease-associated forms alter spines. Nat Neurosci, 2009, 12: 1275–1284
18. Kawasaki H, Springett GM, Mochizuki N, Toki S, Nakaya M, Matsuda M, Housman DE, Graybiel AM. A family of cAMP-binding proteins that directly activate Rap1. Science, 1998, 282: 2275–2279
19. Whitaker CM, Cooper NGF. Differential distribution of exchange proteins directly activated by cyclic AMP within the adult rat retina. Neuroscience, 2010, 165: 955–967
20. Kai AK, Lam AK, Chen Y, Tai AC, Zhang X, Lai AK, Yeung PK, Tam S, Wang J, Lam KS, Vanhoutte PM, Bos JL, Chung SS, Xu A, Chung SK. Exchange protein activated by cAMP 1 (Epac1)-deficient mice develop beta-cell dysfunction and metabolic syndrome. FASEB J, 2013, 27: 4122–4135
21. Zhang CL, Katoh M, Shibasaki T, Minami K, Sunaga Y, Takahashi H, Yokoi N, Iwasaki M, Miki T, Seino S. The cAMP sensor Epac2 is a direct target of antidiabetic sulfonylurea drugs. Science, 2009, 325: 607–610
22. Cheung SS, Leung JW, Lam AK, Lam KS, Chung SS, Lo AC, Chung SK. Selective over-expression of endothelin-1 in endothelial cells exacerbates inner retinal edema and neuronal death in ischemic retina. PLoS One, 2011, 6: e26184
23. Li SY, Fu ZJ, Ma H, Jang WC, So KF, Wong D, Lo AC. Effect of lutein on retinal neurons and oxidative stress in a model of acute retinal ischemia/reperfusion. Invest Ophthalmol Vis Sci, 2009, 50: 836–843
24. Fu ZJ, Li SY, Kociok N, Wong D, Chung SK, Lo AC. Aldose reductase deficiency reduced vascular changes in neonatal mouse retina in oxygen-induced retinopathy. Invest Ophthalmol Vis Sci, 2012, 53: 5698–5712
25. Li SY, Yang D, Yeung CM, Yu WY, Chang RC, So KF, Wong D, Lo AC. Lycium barbarum polysaccharides reduce neuronal damage, blood-retinal barrier disruption and oxidative stress in retinal ischemia/reperfusion injury. PLoS One, 2011, 6: e16380
26. Shibasaki T, Takahashi H, Miki T, Sunaga Y, Matsumura K, Yamanaka M, Zhang C, Tamamoto A, Satoh T, Miyazaki J, Seino S. Essential role of Epac2/Rap1 signaling in regulation of insulin granule dynamics by cAMP. Proc Natl Acad Sci USA, 2007, 104: 19333–19338
27. Pannicke T, Uckermann O, Iandiev I, Biedermann B, Wiedemann P, Perlman I, Reichenbach A, Bringmann A. Altered membrane physiology in Muller glial cells after transient ischemia of the rat retina. Glia, 2005, 50: 1–11
28. Tso MO. Pathology of cystoid macular edema. Ophthalmology, 1982, 89: 902–915
29. Lo AC, Chen AY, Hung VK, Yaw LP, Fung MK, Ho MC, Tsang MC, Chung SS, Chung SK. Endothelin-1 overexpression leads to further water accumulation and brain edema after middle cerebral artery occlusion via aquaporin 4 expression in astrocytic end-feet. J Cereb Blood Flow Metab, 2005, 25: 998–1011
30. Avellini C, Baccarani U, Trevisan G, Cesaratto L, Vascotto C, D’Aurizio F, Pandolfi M, Adani GL, Tell G. Redox proteomics and immunohistology to study molecular events during ischemiareperfusion in human liver. Transplant Proc, 2007, 39: 1755–1760
31. Eismann T, Huber N, Shin T, Kuboki S, Galloway E, Wyder M, Edwards MJ, Greis KD, Shertzer HG, Fisher AB, Lentsch AB. Peroxiredoxin-6 protects against mitochondrial dysfunction and liver injury during ischemia-reperfusion in mice. Am J Physiol Gastrointest Liver Physiol, 2009, 296: G266–274
32. Nagy N, Malik G, Fisher AB, Das DK. Targeted disruption of peroxiredoxin 6 gene renders the heart vulnerable to ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol, 2006, 291: H2636–2640
33. Zhang X, Yeung PK, McAlonan GM, Chung SS, Chung SK. Transgenic mice over-expressing endothelial endothelin-1 show cognitive deficit with blood-brain barrier breakdown after transient ischemia with long-term reperfusion. Neurobiol Learn Mem, 2013, 101: 46–54
34. Ouyang M, Zhang L, Zhu JJ, Schwede F, Thomas SA. Epac signaling is required for hippocampus-dependent memory retrieval. Proc Natl Acad Sci USA, 2008, 105: 11993–11997
35. Dwivedi Y, Mondal AC, Rizavi HS, Faludi G, Palkovits M, Sarosi A, Conley RR, Pandey GN. Differential and brain region-specific regulation of Rap-1 and Epac in depressed suicide victims. Arch Gen Psychiatry, 2006, 63: 639–648
36. Gekel I, Neher E. Application of an Epac activator enhances neurotransmitter release at excitatory central synapses. J Neurosci, 2008, 28: 7991–8002
37. Roscioni SS, Elzinga CR, Schmidt M. Epac: effectors and biological functions. Naunyn Schmiedebergs Arch Pharmacol, 2008, 377: 345–357
38. Suzuki S, Yokoyama U, Abe T, Kiyonari H, Yamashita N, Kato Y, Kurotani R, Sato M, Okumura S, Ishikawa Y. Differential roles of Epac in regulating cell death in neuronal and myocardial cells. J Biol Chem, 2010, 285: 24248–24259
39. Wittchen ES, Hartnett ME. The small GTPase Rap1 is a novel regulator of RPE cell barrier function. Invest Ophthalmol Vis Sci, 2011, 52: 7455–7463
40. Kolb H. The architecture of functional neural circuits in the vertebrate retina. The Proctor Lecture. Invest Ophthalmol Vis Sci, 1994, 35: 2385–2404
41. Yang Y, Shu X, Liu D, Shang Y, Wu Y, Pei L, Xu X, Tian Q, Zhang J, Qian K, Wang YX, Petralia RS, Tu W, Zhu LQ, Wang JZ, Lu Y. EPAC null mutation impairs learning and social interactions via aberrant regulation of miR-124 and Zif268 translation. Neuron, 2012, 73: 774–788